GlobeNewswire — Public Companies·CA·
Canada’s Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement of LEQEMBI® (lecanemab) for Early Alzheimer’s Disease
An Important Step Forward for Access to LEQEMBI® for Eligible Patients in Canada An Important Step Forward for Access to LEQEMBI® for Eligible Patients in Canada
Read releases like this the second they cross the wire.
1,100+ feeds from 80+ newswires in one live cockpit — saved searches, instant alerts, AI summaries. 7-day free trial, no card required.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live on PPN World.
PPN Source →Shared via PPN World — real-time press release intelligence.